- Client News
Cure Pharma launches chewable drug delivery system
CURE Pharmaceutical just announced the expansion of its oral drug delivery product line creating CUREform™ which includes CUREfilm®, one of…
News
- Client News
CURE Pharmaceutical secures patent on oral thin films
CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the allowance of U.S. Application No. 15/666,057, which…
- Client News
CURE Pharmaceutical partners with Canada’s Canopy Growth
CURE Pharmaceutical Holding Corp has entered into a partnership with Canadian cannabis giant Canopy Growth Corp to develop a CBD…
- Client News
CURE Pharmaceutical’s Jessica Rousset on PharmaVOICE’s “Woman of the Week” podcast
CURE Pharmaceutical’s Jessica Rousset was just featured on PharmaVOICE’s “Woman of the Week” podcast. “Jessica Rousset, a technologist, is not…
- Client News
CURE Pharmaceutical secures patent on oral thin film containing bioactive cannabinoid molecules
CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced the issuance of U.S. Patent No. 10,307,397, which covers…
- Client News
CURE Pharmaceutical expands leadership team
CURE Pharmaceutical (OTCQB:CURR) has announced four key hires to grow their leadership team. Michael Redard will serve as CURE’s Chief…
- Client News
CURE Pharmaceutical’s Rob Davidson on Uptick Newswire
CEO Robert Davidson of CURE Pharmaceutical returns to Uptick Newswire to talk about licenses granted to them for cannibinoids, working…
- Client News
CURE Pharmaceutical expands DEA license to manufacture cannabinoid molecules
CURE Pharmaceutical announced it has broadened its U.S. Drug Enforcement Administration (DEA) license as an authorized manufacturer of Schedule 1 substances to include both cannabis plant extracts and synthetic cannabidiol (CBD).
- Client News
CURE Pharmaceutical joins forces with Canopy Growth in exclusive partnership
CURE Pharmaceutical has signed a deal with Canopy Growth Corp (TSX:WEED, NYSE:CGC), where Canopy will have an exclusive license to…
- Client News
Ventura County Star features Oxnard-based CURE Pharmaceutical
Interest in cannabis-based medicine is on the rise, and Oxnard-based CURE Pharmaceutical is positioning itself to become a key player…